Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
38
# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
72%
ALSO IN IBB
IBB
254
HOLDINGS
19%
ALSO IN CANC
SECTOR DRIFT (CANC minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.4% | 9.0% | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 1.7% | 1.9% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 5.9% | 1.4% | 1.4% |
|
GILEAD SCIENCES INC | 1.2% | 9.8% | 1.2% |
 |
GENMAB A/S SPONSORED ADR | 2.9% | 1.2% | 1.2% |
CANC Overweight Relative to IBB
 |
NOVARTIS AG | 4.5% |
|
REVOLUTION MEDICINES, INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.4% |
|
ELI LILLY & CO | 4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.0% |
|
BRISTOL-MYERS SQUIBB CO | 3.6% |
|
MERCK & CO. INC. | 3.5% |
|
IMMUNOME, INC. | 3.2% |
|
ARCELLX, INC. | 3.2% |
|
CELCUITY INC. | 3.2% |
CANC Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -9.2% |
|
GILEAD SCIENCES INC | -8.6% |
|
AMGEN INC | -6.6% |
|
REGENERON PHARMACEUTICALS | -5.9% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
INSMED INC | -2.7% |
 |
ARGENX SE ADR | -2.6% |
|
BIOGEN IDEC INC | -2.4% |
|
UNITED THERAPEUTICS CORP | -2.0% |
|
NATERA INC | -1.7% |